ARVINAS, INC.
ARVN
31 insider filings · Latest: Jun 24, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Jun 24, 2026 | Jun 24 9:20 PM | Andrew SaikChief Financial Officer | Sale | 5,696 | $8.16 | $46.5K | 187,432(D) | View → |
| Jun 24, 2026 | Jun 23 10:09 PM | Andrew Saik | Proposed Sale | 5,846 | $8.14 | $47.6K | — | View → |
| Jun 17, 2026 | Jun 18 8:06 PM | Angela M CacaceChief Scientific Officer | Sale | 2,576 | $7.60 | $19.6K | 180,390(D) | View → |
| Jun 17, 2026 | Jun 17 12:59 PM | Angela Cacace | Proposed Sale | 2,642 | $7.42 | $19.6K | — | View → |
| May 21, 2026 | May 22 8:15 PM | Randy TeelDirector, President and CEO | Sale | 2,209 | $9.04 | $20.0K | 285,009(D) | View → |
| May 21, 2026 | May 20 9:34 PM | Randy Teel | Proposed Sale | 2,197 | $9.10 | $20.0K | — | View → |
| May 11, 2026 | May 13 8:18 PM | Andrew SaikChief Financial Officer | Sale | 11,139 | $9.94 | $110.7K | 193,128(D) | View → |
| May 11, 2026 | May 13 8:17 PM | David K LoomisVP, Chief Accounting Officer | Sale | 1,919 | $9.94 | $19.1K | 40,193(D) | View → |
| May 11, 2026 | May 13 8:16 PM | Angela M CacaceChief Scientific Officer | Sale | 9,657 | $9.94 | $96.0K | 182,966(D) | View → |
| May 11, 2026 | May 13 8:16 PM | Berkowitz NoahChief Medical Officer | Sale | 11,108 | $9.94 | $110.4K | 191,395(D) | View → |
| May 11, 2026 | May 13 8:15 PM | Randy TeelDirector, President and CEO | Sale | 9,657 | $9.94 | $96.0K | 287,218(D) | View → |
| May 11, 2026 | May 8 10:06 PM | Andrew Saik | Proposed Sale | 11,343 | $10.11 | $114.7K | — | View → |
| May 11, 2026 | May 8 10:06 PM | Angela Cacace | Proposed Sale | 9,834 | $10.11 | $99.4K | — | View → |
| May 11, 2026 | May 8 10:05 PM | Noah Berkowitz | Proposed Sale | 11,312 | $10.11 | $114.4K | — | View → |
| May 11, 2026 | May 8 10:05 PM | Randy Teel | Proposed Sale | 9,834 | $10.11 | $99.4K | — | View → |
| Mar 18, 2026 | Mar 20 12:01 AM | Berkowitz NoahChief Medical Officer | Sale | 6,435 | $11.10 | $71.4K | 202,503(D) | View → |
| Mar 18, 2026 | Mar 17 11:25 PM | Noah Berkowitz | Proposed Sale | 6,022 | $12.01 | $72.3K | — | View → |
| Mar 6, 2026 | Mar 9 8:05 PM | Briggs MorrisonDirector | Purchase | 20,000 | $13.40 | $268.1K | 96,021(D) | View → |
| Feb 27, 2026 | Mar 3 1:57 AM | John G HoustonDirector | Sale | 35,297 | $13.21 | $466.2K | 1,122,183(D) | View → |
| Feb 27, 2026 | Feb 27 9:02 PM | John G. Houston | Proposed Sale | 35,297 | $13.21 | $466.2K | — | View → |
Page 1 of 2
Next →
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Jun 24, 2026 | Jun 26 8:23 PM | Alsup Laurie SmaldoneDirector | Grant/Award | 22,714 | $8.05 | 22,714(D) | View → |
| Jun 24, 2026 | Jun 26 8:23 PM | Leslie V NorwalkDirector | Grant/Award | 22,714 | $8.05 | 22,714(D) | View → |
| Jun 24, 2026 | Jun 26 8:22 PM | Briggs MorrisonDirector | Grant/Award | 22,714 | $8.05 | 22,714(D) | View → |
| Jun 24, 2026 | Jun 26 8:22 PM | Edward Moore Kennedy Jr.Director | Grant/Award | 22,714 | $8.05 | 22,714(D) | View → |
| Jun 24, 2026 | Jun 26 8:21 PM | Everett CunninghamDirector | Grant/Award | 22,714 | $8.05 | 22,714(D) | View → |
| Jun 24, 2026 | Jun 26 8:21 PM | Linda BainDirector | Grant/Award | 22,714 | $8.05 | 22,714(D) | View → |
| Feb 26, 2026 | Mar 3 2:01 AM | David K LoomisVP, Chief Accounting Officer | Grant/Award | 18,504 | $13.38 | 18,504(D) | View → |
| Feb 26, 2026 | Mar 3 2:00 AM | Angela M CacaceChief Scientific Officer | Grant/Award | 67,000 | $13.38 | 67,000(D) | View → |
| Feb 26, 2026 | Mar 3 1:59 AM | Berkowitz NoahChief Medical Officer | Grant/Award | 67,000 | $13.38 | 67,000(D) | View → |
| Feb 26, 2026 | Mar 3 1:58 AM | Andrew SaikChief Financial Officer | Grant/Award | 67,000 | $13.38 | 67,000(D) | View → |
| Feb 26, 2026 | Mar 3 1:58 AM | Randy TeelDirector, President and CEO | Grant/Award | 218,691 | $13.38 | 218,691(D) | View → |